Access to New Therapies in Romania Through the Scorecard HTA System

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.148
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Demands for Access to New Therapies: Are There Alternatives to Accelerated Access?

British Medical Journal
Medicine
2017English

The Access to Performance in Romanian Academic System Possibilities for Increasing the Competitiveness of Universities in Romania

DEStech Transactions on Social Science, Education and Human Science
2017English

Equity of Access to Psychological Therapies

British Journal of Psychiatry
MedicinePsychiatryMental Health
2011English

Controversies Regarding the Sportsmen Access to National Championships Podium in Romania

2017English

Php38 - Enzyme Replacement Therapies Within the German Hta (Amnog) Process

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Are Payers Ready, Willing, and Able to Provide Access to New Durable Gene Therapies?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Php301 - The Time Is Now for European Hta: How Will the Evolution of European Hta Impact Access to Innovative Medicines?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Human Resources in the Balanced Scorecard System

2009English

Pnd99 - Cystic Fibrosis Therapies - Key Drivers Behind Differing Hta Decisions

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy